Show simple item record

dc.contributor.authorConseil exécutif, 102
dc.coverage.spatialGenèveen
dc.date.accessioned2013-05-11T14:51:26Z
dc.date.available2013-05-11T14:51:26Z
dc.date.issued1998
dc.identifier.govdocEB102/9
dc.identifier.urihttp://www.who.int/iris/handle/10665/81768
dc.descriptionConseil exécutif, cent deuxième session, Point 8 de l’ordre du jour provisoireen
dc.description9 p.en
dc.language.isofren
dc.publisherOrganisation mondiale de la Santéen
dc.subjectFood safetyen
dc.subjectPharmaceutical productsen
dc.subjectVaccinesen
dc.subject.meshDrug Residuesen
dc.subject.meshFood Contaminationen
dc.subject.meshVeterinary Drugsen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshReference Standardsen
dc.subject.meshVaccines, DNAen
dc.subject.meshFood Irradiationen
dc.subject.meshRadiation Dosageen
dc.titleRapports des organes consultatifs et questions connexes : Rapport sur les réunions de comités d’experts et de groupes d’étude : Rapport du Directeur généralen
dc.typeGoverning body documentsen
dc.subject.meshqualifieradverse effectsen
dc.subject.meshqualifierstandardsen
who.relation.languageVersion10665/82288en
who.relation.languageVersion10665/63889en
who.relation.languageVersion10665/79919en
who.relation.languageVersion10665/81225en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record